These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 29130542)

  • 1. Safety evaluation of p-synephrine following 15 days of oral administration to healthy subjects: A clinical study.
    Shara M; Stohs SJ; Smadi MM
    Phytother Res; 2018 Jan; 32(1):125-131. PubMed ID: 29130542
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cardiovascular Safety of Oral p-Synephrine (Bitter Orange) in Healthy Subjects: A Randomized Placebo-Controlled Cross-over Clinical Trial.
    Shara M; Stohs SJ; Mukattash TL
    Phytother Res; 2016 May; 30(5):842-7. PubMed ID: 26948284
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A 60day double-blind, placebo-controlled safety study involving Citrus aurantium (bitter orange) extract.
    Kaats GR; Miller H; Preuss HG; Stohs SJ
    Food Chem Toxicol; 2013 May; 55():358-62. PubMed ID: 23354394
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A review of the human clinical studies involving Citrus aurantium (bitter orange) extract and its primary protoalkaloid p-synephrine.
    Stohs SJ; Preuss HG; Shara M
    Int J Med Sci; 2012; 9(7):527-38. PubMed ID: 22991491
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of acute administration of an herbal preparation on blood pressure and heart rate in humans.
    Seifert JG; Nelson A; Devonish J; Burke ER; Stohs SJ
    Int J Med Sci; 2011 Mar; 8(3):192-7. PubMed ID: 21448304
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Acute cardiovascular effects of bitter orange extract (p-synephrine) consumed alone and in combination with caffeine in human subjects: A placebo-controlled, double-blind study.
    Ratamess NA; Bush JA; Stohs SJ; Ellis NL; Vought IT; O'Grady EA; Kuper JD; Hasan SB; Kang J; Faigenbaum AD
    Phytother Res; 2018 Jan; 32(1):94-102. PubMed ID: 29047215
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Physiological effects following administration of Citrus aurantium for 28 days in rats.
    Hansen DK; George NI; White GE; Pellicore LS; Abdel-Rahman A; Fabricant D;
    Toxicol Appl Pharmacol; 2012 Jun; 261(3):236-47. PubMed ID: 22521485
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The safety of Citrus aurantium (bitter orange) and its primary protoalkaloid p-synephrine.
    Stohs SJ; Preuss HG; Shara M
    Phytother Res; 2011 Oct; 25(10):1421-8. PubMed ID: 21480414
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Safety, Efficacy, and Mechanistic Studies Regarding Citrus aurantium (Bitter Orange) Extract and p-Synephrine.
    Stohs SJ
    Phytother Res; 2017 Oct; 31(10):1463-1474. PubMed ID: 28752649
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Acute hematological and mood perception effects of bitter orange extract (p-synephrine) consumed alone and in combination with caffeine: A placebo-controlled, double-blind study.
    Bush JA; Ratamess NA; Stohs SJ; Ellis NL; Vought IT; O'Grady EA; Kuper JD; Kang J; Faigenbaum AD
    Phytother Res; 2018 Aug; 32(8):1593-1607. PubMed ID: 29672965
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Risk assessment of synephrine in dietary supplements].
    Bakhyia N; Dusemund B; Richter K; Lindtner O; Hirsch-Ernst KI; Schäfer B; Lampen A
    Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2017 Mar; 60(3):323-331. PubMed ID: 28058460
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hemodynamic effects of ephedra-free weight-loss supplements in humans.
    Haller CA; Benowitz NL; Jacob P
    Am J Med; 2005 Sep; 118(9):998-1003. PubMed ID: 16164886
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Synephrine in dietary supplements and specialized foodstuffs: biological activity, safety and methods of analysis].
    Perova IB; Eller KI; Musatov AV; Tymolskaya EV
    Vopr Pitan; 2021; 90(6):101-113. PubMed ID: 35032130
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Citrus aurantium (bitter orange) extract: Safety assessment by acute and 14-day oral toxicity studies in rats and the Ames Test for mutagenicity.
    Deshmukh NS; Stohs SJ; Magar CC; Kadam SB
    Regul Toxicol Pharmacol; 2017 Nov; 90():318-327. PubMed ID: 28966104
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A review of the receptor-binding properties of p-synephrine as related to its pharmacological effects.
    Stohs SJ; Preuss HG; Shara M
    Oxid Med Cell Longev; 2011; 2011():482973. PubMed ID: 21904645
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of Citrus aurantium (bitter orange) fruit extracts and p-synephrine on metabolic fluxes in the rat liver.
    Peixoto JS; Comar JF; Moreira CT; Soares AA; de Oliveira AL; Bracht A; Peralta RM
    Molecules; 2012 May; 17(5):5854-69. PubMed ID: 22592089
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cardiovascular toxicity of Citrus aurantium in exercised rats.
    Hansen DK; George NI; White GE; Abdel-Rahman A; Pellicore LS; Fabricant D
    Cardiovasc Toxicol; 2013 Sep; 13(3):208-19. PubMed ID: 23397375
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Screening for in vivo (anti)estrogenic activity of ephedrine and p-synephrine and their natural sources Ephedra sinica Stapf. (Ephedraceae) and Citrus aurantium L. (Rutaceae) in rats.
    Arbo MD; Franco MT; Larentis ER; Garcia SC; Sebben VC; Leal MB; Dallegrave E; Limberger RP
    Arch Toxicol; 2009 Jan; 83(1):95-9. PubMed ID: 18651134
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mass spectrometric determination of the predominant adrenergic protoalkaloids in bitter orange (Citrus aurantium).
    Nelson BC; Putzbach K; Sharpless KE; Sander LC
    J Agric Food Chem; 2007 Nov; 55(24):9769-75. PubMed ID: 17966980
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Review of Published Bitter Orange Extract and
    Stohs SJ; Ray SD
    J Diet Suppl; 2020; 17(3):355-363. PubMed ID: 30835576
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.